REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 55 filers reported holding REGULUS THERAPEUTICS INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $1,000 | -66.7% | 4 | 0.0% | 0.00% | – |
| Q2 2018 | $3,000 | 0.0% | 4 | 0.0% | 0.00% | – |
| Q1 2018 | $3,000 | -25.0% | 4 | 0.0% | 0.00% | – |
| Q4 2017 | $4,000 | -20.0% | 4 | 0.0% | 0.00% | – |
| Q3 2017 | $5,000 | +25.0% | 4 | 0.0% | 0.00% | – |
| Q2 2017 | $4,000 | -99.3% | 4 | -98.8% | 0.00% | – |
| Q1 2017 | $563,000 | -88.7% | 341 | -84.6% | 0.00% | – |
| Q4 2016 | $4,977,000 | -42.2% | 2,212 | -15.3% | 0.00% | – |
| Q3 2016 | $8,616,000 | +97.7% | 2,611 | +73.1% | 0.00% | – |
| Q2 2016 | $4,358,000 | -91.2% | 1,508 | -73.5% | 0.00% | – |
| Q4 2015 | $49,582,000 | -79.4% | 5,686 | -84.5% | 0.00% | -100.0% |
| Q3 2015 | $240,437,000 | +832.3% | 36,764 | +1462.4% | 0.00% | – |
| Q2 2015 | $25,789,000 | +312.6% | 2,353 | +537.7% | 0.00% | – |
| Q1 2015 | $6,251,000 | -16.4% | 369 | -66.3% | 0.00% | – |
| Q3 2014 | $7,479,000 | +667.1% | 1,095 | +729.5% | 0.00% | – |
| Q4 2013 | $975,000 | – | 132 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|